Raechel T. White, PharmD, PhC, BCACP

Taneja College of Pharmacy, University of South Florida, Tampa, Florida

  • 2Articles
  • 8.3KReads
  • 2024–2025Active
  • 2Collaborators

About

Raechel T. White, PharmD, PhC, BCACP is affiliated with Taneja College of Pharmacy, University of South Florida, Tampa, Florida. Raechel T. White has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2024 and 2025. Their work focuses on Metabolic Disorders, Posttraumatic Stress Disorder, and Psychiatry.

Publications

PCC
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use
Narrative Review

Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use

September 4, 2025

Incretin therapies have emerged as a promising treatment option with potential benefits for mitigating cardiometabolic side effects associated with antipsychotics; however, clinical trials have often excluded psychiatric populations.
,
PCC
Treatment of Trauma-Related Nightmares With Terazosin
Case Report

Treatment of Trauma-Related Nightmares With Terazosin

March 5, 2024

After a failed trial of prazosin, a switch to terazosin was efficacious in reducing the severity and frequency of trauma-related nightmares.
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe